Odonate Therapeutics, Inc (ODT)

Etorro trading 970x250
Odonate Therapeutics, Inc (ODT) Logo

About Odonate Therapeutics, Inc

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York. Address: 3 East 28th Street, New York, NY, United States, 10016

Odonate Therapeutics, Inc News and around…

Latest news about Odonate Therapeutics, Inc (ODT) common stock and company :

60 Biggest Movers From Yesterday
11 Jan, 2022 FinancialContent

Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) ...

56 Biggest Movers From Friday
10 Jan, 2022 FinancialContent

Gainers Hour Loop, Inc.(NASDAQ: HOUR) shares jumped 99.8% to $7.99after the company priced its IPO at $4 per ...

12 Health Care Stocks Moving In Friday's Intraday Session
07 Jan, 2022 FinancialContent

Gainers Absci (NASDAQ:ABSI) stock increased by 28.2% to $7.87 during Friday's regular session. As of 12:30 EST, ...

Stocks That Hit 52-Week Lows On Friday
07 Jan, 2022 FinancialContent

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana ...

Odonate Announces Expected Delisting of Its Stock
07 Jan, 2022 FinancialContent

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying Odonate that Nasdaq believes that Odonate is a "public shell" pursuant to Listing Rule 5101, and that the continued listing of its securities is no longer warranted. Odonate will not appeal this determination. Therefore, Odonate expects the trading of its common stock on The Nasdaq Stock Market to be suspended at the opening of business on January 18, 2022, and that Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission (the “SEC”), which will remove Odonate’s securities from listing and registration on The Nasdaq Stock Market. Additionally, Odonate intends to file with the SEC a Form 15 requesting the suspension of the Company’s reporting obligations.

ODONATE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Odonate Therapeutics, Inc. - ODT
11 Dec, 2021 Yahoo! Finance

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into Odonate Therapeutics, Inc. (NasdaqGS: ODT).

12 Health Care Stocks Moving In Wednesday's After-Market Session
08 Dec, 2021 FinancialContent

Gainers Aptinyx (NASDAQ:APTX) shares rose 4.72% to $2.66 during Wednesday's after-market session. Trading volume for this security ...

Odonate Therapeutics Insider Sold Over $2.5M In Company Stock
22 Nov, 2021 Yahoo! Finance

Aaron I Davis, Insider at Odonate Therapeutics (NASDAQ:ODT), made a large insider sell on November 19, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Davis sold 1,200,000 shares of Odonate Therapeutics at prices ranging from $1.84 to $2.23. The total transaction amounted to $2,499,948. Following the transaction, Davis still owns 4,607,086 shares of Odonate Therapeutics worth $7,832,046.00. Odonate Therapeutics

54 Biggest Movers From Yesterday
19 Nov, 2021 FinancialContent

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare ...

12 Health Care Stocks Moving In Thursday's Intraday Session
18 Nov, 2021 FinancialContent

Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) shares moved upwards by 78.87% to $38.06 during Thursday's regular ...

44 Stocks Moving In Thursday's Mid-Day Session
18 Nov, 2021 FinancialContent

Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation ...

61 Biggest Movers From Yesterday
18 Nov, 2021 FinancialContent

Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at ...

Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan
17 Nov, 2021 FinancialContent

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that it will commence a share repurchase plan for up to 20 million shares in order to return capital to stockholders. This action is in connection with the Company’s previously announced decision to discontinue the development of tesetaxel. Repurchases may be made from time to time at the Company’s discretion. The plan has no time limit and can be discontinued at any time. There can be no assurance as to the timing or number of shares of any repurchases.

Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021
10 Nov, 2021 FinancialContent

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and nine months ended September 30, 2021.

SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm
08 Sep, 2021 FinancialContent
A Odonate Therapeutics, Inc. (NASDAQ:ODT) insider increased their holdings last year
06 Sep, 2021 Yahoo! Finance

Looking at Odonate Therapeutics, Inc.'s ( NASDAQ:ODT ) insider transactions over the last year, we can see that...

ODONATE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Odonate Therapeutics, Inc. - ODT
21 Aug, 2021 FinancialContent

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Odonate Therapeutics, Inc. (NasdaqGS: ODT).

Update in Lawsuit for Investors in Odonate Therapeutics, Inc. (NASDAQ:ODT) Announced by Shareholders Foundation
17 Aug, 2021 Yahoo! Finance

SAN DIEGO, CA / ACCESSWIRE / August 17, 2021 / The Shareholders Foundation, Inc. announces an update in the lawsuit that is pending for certain investors in (NASDAQ:ODT) shares.

Kaskela Law LLC Announces Stockholder Investigation of Odonate Therapeutics, Inc. - ODT
16 Aug, 2021 Yahoo! Finance

PHILADELPHIA, PA / ACCESSWIRE / August 16, 2021 / Kaskela Law LLC announces that it is investigating Odonate Therapeutics, Inc. ("Odonate" or the "Company") (Nasdaq:ODT).

SHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to Investors
13 Aug, 2021 Yahoo! Finance

Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Odonate Therapeutics, Inc. (NASDAQ: ODT) relating to possible false statements to investors regarding its only product, tesetaxel, a drug the company was formerly developing for the treatment of breast cancer.

NASDAQ: ODT Investor Notice: Update in Lawsuit against Odonate Therapeutics, Inc. announced by Shareholders Foundation
10 Aug, 2021 FinancialContent
The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors
06 Aug, 2021 FinancialContent

The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors

Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021
27 Jul, 2021 FinancialContent

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and six months ended June 30, 2021.

12 Health Care Stocks Moving In Friday's After-Market Session
23 Jul, 2021 FinancialContent

Gainers NanoVibronix (NASDAQ:NAOV) shares rose 21.45% to $3.17 during Friday's after-market session. This security traded at a ...

12 Health Care Stocks Moving In Monday's After-Market Session
19 Jul, 2021 FinancialContent

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares moved upwards by 25.88% to $3.55 during Monday's after-market session. This ...

Thursday's ETF with Unusual Volume: IBBQ
08 Jul, 2021 FinancialContent

The Invesco Nasdaq Biotechnology ETF is seeing unusually high volume in afternoon trading Thursday, with over 271,000 shares traded versus three month average volume of about 32,000. Shares of IBBQ were up about 0.1% on the day.

12 Health Care Stocks Moving In Thursday's Pre-Market Session
08 Jul, 2021 FinancialContent

Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock moved upwards by 43.27% to $2.45 during Thursday's pre-market ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
07 Jul, 2021 FinancialContent

Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The ...

25 Stocks Moving in Wednesday's Pre-Market Session
07 Jul, 2021 FinancialContent

Gainers Opiant Pharmaceuticals Inc (NASDAQ: OPNT) shares rose 50.9% to $20.00 in pre-market trading after the company disclosed ...

Top Biotech Penny Stocks to Buy This Week? 9 To Watch
06 Jul, 2021 FinancialContent

Odonate Therapeutics, Inc (ODT) is a NASDAQ Common Stock listed in , ,

970x250